| ICD |
Diagnosis |
Cases |
| Y51.8 |
Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified |
0 |
| Y51.7 |
Beta-adrenoreceptor antagonists, not elsewhere classified |
0 |
| Y51.6 |
Alpha-adrenoreceptor antagonists, not elsewhere classified |
0 |
| Y51.4 |
Predominantly alpha-adrenoreceptor agonists, not elsewhere classified |
0 |
| Y51.2 |
Ganglionic blocking drugs, not elsewhere classified |
0 |
| Y51.1 |
Other parasympathomimetics [cholinergics] |
0 |
| Y51.0 |
Anticholinesterase agents |
0 |
| Y51 |
Drugs primarily affecting the autonomic nervous system |
0 |
| Y50.8 |
Other central nervous system stimulants |
0 |
| Y50.2 |
Methylxanthines, not elsewhere classified |
0 |
| Y50.1 |
Opioid receptor antagonists |
0 |
| Y50.0 |
Analeptics |
0 |
| Y50 |
Central nervous system stimulants, not elsewhere classified |
0 |
| Y49.8 |
Other psychotropic drugs, not elsewhere classified |
0 |
| Y49.6 |
Psychodysleptics [hallucinogens] |
0 |
| Y49.3 |
Phenothiazine antipsychotics and neuroleptics |
0 |
| Y49.1 |
Monoamine-oxidase-inhibitor antidepressants |
0 |
| Y49.0 |
Tricyclic and tetracyclic antidepressants |
0 |
| Y49 |
Psychotropic drugs, not elsewhere classified |
0 |
| Y48.5 |
Therapeutic gases |
0 |
| Y48.4 |
Anaesthetic, unspecified |
0 |
| Y48.3 |
Local anaesthetics |
0 |
| Y48.2 |
Other and unspecified general anaesthetics |
0 |
| Y48.1 |
Parenteral anaesthetics |
0 |
| Y48.0 |
Inhaled anaesthetics |
0 |
| Y48 |
Anaesthetics and therapeutic gases |
0 |
| Y47.8 |
Other sedatives, hypnotics and antianxiety drugs |
0 |
| Y47.5 |
Mixed sedatives and hypnotics, not elsewhere classified |
0 |
| Y47.3 |
Paraldehyde |
0 |
| Y46.8 |
Antispasticity drugs |
0 |
| Y46.7 |
Antiparkinsonism drugs |
0 |
| Y46.3 |
Deoxybarbiturates |
0 |
| Y46.1 |
Oxazolidinediones |
0 |
| Y46.0 |
Succinimides |
0 |
| Y45.4 |
Antirheumatics |
0 |
| Y44.9 |
Other and unspecified agents affecting blood constituents |
0 |
| Y44.7 |
Plasma substitutes |
0 |
| Y44.6 |
Natural blood and blood products |
0 |
| Y44.5 |
Thrombolytic drugs |
0 |
| Y44.4 |
Antithrombotic drugs [platelet-aggregation inhibitors] |
0 |
| Y44.3 |
Anticoagulant antagonists, vitamin K and other coagulants |
0 |
| Y44.1 |
Vitamin B 12 , folic acid and other anti-megaloblastic-anaemia preparations |
0 |
| Y43.6 |
Enzymes, not elsewhere classified |
0 |
| Y43.4 |
Immunosuppressive agents |
0 |
| Y43.2 |
Antineoplastic natural products |
0 |
| Y43 |
Primarily systemic agents |
0 |
| Y42.9 |
Other and unspecified hormone antagonists |
0 |
| Y42.6 |
Antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified |
0 |
| Y42.5 |
Other estrogens and progestogens |
0 |
| Y42.3 |
Insulin and oral hypoglycaemic [antidiabetic] drugs |
0 |
